Professor Youlia M. Kirova, MD is a senior radiation oncologist, Professor in the Department of Radiation Oncology of the Institut Curie, Paris & University Versailles St Quentin. She is a head of the breast cancer research and treatment, as well as the research and treatment of haematological malignancies. Involved in patients’ care as well as in the clinical and translational research, she participates in the development of new treatment protocols, innovations in radiotherapy techniques.
Youlia Kirova is involved in teaching nationally (SFRO, FROG, SFSMP) and internationally, as a teacher in ESTRO EBRO teaching courses as well as ESO, ESSO, ASTRO, RSNA.
She is an active member of the Steering Committee ILROG.
Pr Kirova is a vice president of FROG and Former member of International SIOG Radiotherapy Task Force.
Member of Lymphoma PTCOG Lymphoma and co-chair of PTCOG Breast SubCommittees
Core Member of ESTRO HEMATOLOGY Focus Group
Former Vice President of ESTRO RT-Systemic Treatment associations Focus Group (2021-2026)
Member of Cardiac substructures ESTRO Group
She is Deputy Chief Editor of Cancer Radiothérapie, and member of Editorial committees of International Journal of Radiation Oncology, Biology, Physics (2021-2025), EJSO, ITO
Visiting Professor in Harvard University, USA (2018-2023)
Pr Youlia M. Kirova is PI in numerous national and international phase I, II, and III studies. She is involved in the translational work of the Institut Curie, Paris.
She authored and co-authored more than 480 articles and several book chapters; see also PubMed (http://www.ncbi.nlm.nih.gov/sites/), Google Scholar and CancerLit
Disclosures:
- Employment: none
- Compensation: none
- Ownership: none
- Leadership: none